What are the normal diameters of the left atrium, right atrium, and right ventricle as recommended by the American Society of Echocardiography?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ASE Normal Reference Values for Cardiac Chamber Dimensions

According to the 2015 ASE/EACVI guidelines, the normal upper limits are: Left Atrium anteroposterior diameter ≤40 mm (men) and ≤38 mm (women), Right Ventricle basal diameter <41 mm and mid-cavity <35 mm, and Right Atrium dimensions should be assessed primarily by volume rather than linear measurements. 1

Left Atrium

The ASE guidelines emphasize that LA volume is the preferred measurement over linear dimensions because it better reflects true chamber size and has stronger prognostic value 1. However, the most commonly used linear measurement remains:

  • LA anteroposterior (AP) diameter measured in parasternal long-axis view:
    • Normal: ≤40 mm (men), ≤38 mm (women)
    • Measured at end-systole using 2D-guided measurement perpendicular to the aortic root
    • Should be indexed to BSA for accurate interpretation 1

Important caveat: The AP diameter alone often underestimates LA enlargement because the atrium doesn't dilate uniformly in all directions. LA volume measurement (biplane method of disks) is strongly recommended for comprehensive assessment, with normal indexed values <34 mL/m² 1.

Right Ventricle

The ASE guidelines specify measurements from the RV-focused apical four-chamber view (not the standard LV-centered view) 1:

  • Basal RV diameter (RVD1): <41 mm

    • Measured at the maximal transversal dimension in the basal one-third at end-diastole
  • Mid-cavity RV diameter (RVD2): <35 mm

    • Measured at the middle third, approximately halfway between base and apex, at the level of papillary muscles at end-diastole

Critical technical point: These measurements are highly dependent on probe rotation and view optimization. The report must specify that measurements were obtained from the RV-focused view to permit inter-study comparison 1. A diameter ≥41 mm at the base or ≥35 mm at mid-level indicates RV dilatation 1.

Additional RV outflow tract measurements:

  • Proximal RVOT: measured in parasternal long-axis view at end-diastole
  • Distal RVOT: measured just proximal to pulmonary valve at end-diastole

Right Atrium

The ASE guidelines recommend RA size assessment primarily through area and volume measurements rather than linear dimensions 1. Specific normal linear dimension cutoffs are not provided in the same manner as for LA or RV.

RA assessment should include:

  • Manual tracing of RA endocardial border in apical four-chamber view at end-systole
  • Measurement from lateral tricuspid annulus along free wall to apex and back to medial annulus
  • Exclusion of IVC confluence from the tracing

Key Clinical Pitfalls

  1. Don't use standard four-chamber view for RV measurements - must use RV-focused view with the entire RV free wall optimally visualized 1

  2. Avoid LA foreshortening - the longitudinal axes of LV and LA lie in different planes; obtain dedicated LA acquisitions 1

  3. Index to BSA - gender differences in chamber size are accounted for by BSA indexing, making this essential for accurate interpretation 1

  4. Single linear dimensions underestimate chamber enlargement - particularly for LA and RA, volume measurements provide superior assessment of true chamber size and remodeling 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.